Changes in hemoglobin and related influencing factors in patients with liver failure undergoing artificial liver support therapy

Ying LIN; Li CHEN; Fei PENG; Jianhui LIN; Chuanshang ZHUO

doi:10.12449/JCH250116

Volume 41 Issue 1

Jan. 2025

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2025 > 41(1): 104-109

PDF( 1037 KB)

Changes in hemoglobin and related influencing factors in patients with liver failure undergoing artificial liver support therapy

DOI: 10.12449/JCH250116

Ying LIN^a,
Li CHEN^a,
Fei PENG^a,
Jianhui LIN^{b, c
,
,
,},
Chuanshang ZHUO^{a
,
,
,}

a.
Department of Blood Transfusion Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350001, China
b.
Artificial Liver Center, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350001, China
c.
Department of Liver Diseases, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350001, China

Research funding:

Fuzhou “14th Five-Year Plan” Clinical Key Specialty (20220203);

Natural Science Foundation of Fujian Province (2020J011158);

Natural Science Foundation of Fujian Province (2021J011293)

More Information

Corresponding author: LIN Jianhui， cnfjljh@163.com （ORCID： 0000-0002-6490-8865）; ZHUO Chuanshang， hjjzoe@163.com （ORCID： 0000-0002-7254-3149）
Received Date: 2024-06-06
Accepted Date: 2024-07-04
Published Date: 2025-01-25

Abstract

Abstract

Objective To investigate the changing trend of hemoglobin （Hb） and related influencing factors in patients with liver failure after artificial liver support system （ALSS） therapy. Methods A total of 106 patients with liver failure who were hospitalized and received ALSS therapy in our hospital from January to December 2018 were enrolled and analyzed in terms of clinical data and red blood cell parameters such as Hb， mean corpuscular volume （MCV）， mean corpuscular hemoglobin （MCH）， mean corpuscular hemoglobin concentration （MCHC）， and red blood cell distribution width-coefficient of variation （RDW-CV）. A one-way repeated-measures analysis of variance was used for comparison of continuous data with repeated measurement between groups， and the paired t-test was used for comparison between two groups. The Kruskal-Wallis H test was used for comparison of continuous data with skewed distribution between multiple groups， the Mann-Whitney U test was used for further comparison between two groups. Univariate and multivariate linear regression analyses were used to identify the influencing factors for the reduction in Hb after ALSS therapy. Results The 106 patients with liver failure received 606 sessions of ALSS therapy， and Hb was measured for 402 sessions before and after treatment. There was a significant reduction in Hb after ALSS therapy in the patients with liver failure （97.49±20.51 g/L vs 109.38±20.22 g/L， t=32.764， P<0.001）. Longitudinal observation was further performed for 14 patients with liver failure， and the results showed that the level of Hb was 108.50±21.61 g/L before the last session of ALSS therapy， with certain recovery compared with the level of Hb （103.14±19.15 g/L） on the second day after ALSS， and there was an increase in Hb on day 3 （102.57±21.73 g/L） and day 7 （105.57±22.04 g/L） after surgery. The level of Hb in patients with liver failure on the second day after ALSS decreased with the increase in the number of ALSS sessions （F=8.996， P<0.001）， while MCV and MCH gradually increased with the increase in the number of ALSS sessions （F=9.154 and 13.460， P=0.004 and P<0.001）， and RDW-CV first gradually increased and then gradually decreased （F=4.520， P=0.032）； MCHC showed fluctuations with no clear trend （F=0.811， P=0.494）. The multivariate linear regression analysis showed that the duration of ALSS therapy， the mode of ALSS therapy， and initial treatment were independent risk factors for the reduction in Hb after ALSS therapy. Conclusion ALSS therapy can influence the level of peripheral blood Hb in patients with liver failure， and patient blood management should be strengthened for patients with liver failure who are receiving ALSS therapy.
- Liver Failure,
- Liver， Artificial,
- Hemoglobins

FullText(HTML)

References(18)

References

[1]	Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Associtaion; Severe Liver Disease and artificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association. Guideline for diagnosis and treatment of liver failure(2018)[J]. J Clin Hepatol, 2019, 35( 1): 38- 44. DOI: 10.3969/j.issn.1001-5256.2019.01.007. 中华医学会感染病学分会肝衰竭与人工肝学组, 中华医学会肝病学分会重型肝病与人工肝学组肝衰竭诊治指南(2018年版)[J]. 临床肝胆病杂志, 2019, 35( 1): 38- 44. DOI: 10.3969/j.issn.1001-5256.2019.01.007.
[2]	Severe Liver Disease and Artificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association. Expert consensus on clinical application of artificial liver and blood purification(2022 edition)[J]. J Clin Hepatol, 2022, 38( 5): 767- 775. DOI: 10.3969/j.issn.1001-5256.2022.04.007. 中华医学会肝病学分会重型肝病与人工肝学组人工肝血液净化技术临床应用专家共识(2022年版)[J]. 临床肝胆病杂志, 2022, 38( 4): 767- 775. DOI: 10.3969/j.issn.1001-5256.2022.04.007.
[3]	CAI YF, WANG ZH, CHENG SQ. A comparative study of three non-biological artificial liver models in the treatment of patients with acute-on-chronic liver failure[J/CD]. Chin J Liver Dis(Electronic Version), 2023, 15( 1): 47- 55. DOI: 10.3969/j.issn.1674-7380.2023.01.008. 蔡毅峰, 王朝辉, 程书权. 三种非生物型人工肝模式治疗慢加急性肝衰竭患者的对比研究[J/CD]. 中国肝脏病杂志(电子版), 2023, 15( 1): 47- 55. DOI: 10.3969/j.issn.1674-7380.2023.01.008.
[4]	ZHANG B, DILIHUMAER ZYE, ZHANG SY, et al. Progress on pathogenesis and medical treatment of hepatitis B virus-related chronic and acute liver failure[J/CD]. Chin J Liver Dis(Electronic Version), 2023, 15( 1): 28- 33. DOI: 10.3969/j.issn.1674-7380.2023.01.005. 张斌, 迪丽胡玛尔·扎依尔, 张诗雨, 等. 乙型肝炎相关慢加急性肝衰竭发病机制及治疗进展[J/CD]. 中国肝脏病杂志(电子版), 2023, 15( 1): 28- 33. DOI: 10.3969/j.issn.1674-7380.2023.01.005.
[5]	WANG L, XU WX, ZHU S, et al. Influence of artificial liver support system therapy on platelet in treatment of hepatitis B virus-related acute-on-chronic liver failure[J]. J Clin Hepatol, 2022, 38( 5): 1053- 1058. DOI: 10.3969/j.issn.1001-5256.2022.05.015. 王璐, 许文雄, 朱姝, 等. 人工肝治疗HBV相关慢加急性肝衰竭的血小板计数变化及其影响因素[J]. 临床肝胆病杂志, 2022, 38( 5): 1053- 1058. DOI: 10.3969/j.issn.1001-5256.2022.05.015.
[6]	ZHU MF, HUANG JR, CHEN YM. Treatment with artificial liver support system-plaxma exchange blood cell in the patients of severe hippatitis[J]. Chin J Dial Artif Organs, 2004, 15( 1): 12- 15. 朱梦飞, 黄建荣, 陈月美. 人工肝支持系统治疗对慢性重型肝炎患者近期血细胞影响的研究[J]. 透析与人工器官, 2004, 15( 1): 12- 15.
[7]	ZHANG K, XIE XS, YING YZ. The effect of plasma exchange on recent blood cells in patients with severe hepatitis[J]. Zhejiang Pract Med, 2006, 11( 5): 331, 336. DOI: 10.3969/j.issn.1007-3299.2006.05.017. 张戡, 谢新生, 应雅珍. 血浆置换对重型肝炎患者近期血细胞的影响[J]. 浙江实用医学, 2006, 11( 5): 331, 336. DOI: 10.3969/j.issn.1007-3299.2006.05.017.
[8]	JIA JF, LIANG F, HUANG J, et al. Effect of artificial liver with double plasma molecular absorb system model on patients’ platelets and corresponding treatment strategy[J]. J Peking Univ: Health Sci, 2022, 54( 3): 548- 551. DOI: 10.19723/j.issn.1671-167X.2022.03.022. 贾金凤, 梁菲, 黄建, 等双重血浆分子吸附系统模式人工肝治疗对血小板的影响[J]. 北京大学学报(医学版), 2022, 54( 3): 548- 551. DOI: 10.19723/j.issn.1671-167X.2022.03.022.
[9]	WU YS, ZHANG H, ZHENG WH, et al. Hidden blood loss and the influential factors after percutaneous kyphoplasty surgery[J]. Eur Spine J, 2017, 26( 7): 1878- 1883. DOI: 10.1007/s00586-017-4950-9.
[10]	KAMATH PS, KIM WR, Advanced Liver Disease Study Group. The model for end-stage liver disease(MELD)[J]. Hepatology, 2007, 45( 3): 797- 805. DOI: 10.1002/hep.21563.
[11]	NIE C, SHE GM, LI YL, et al. Effect of cardiopulmonary bypass for 30 min on structure and mechanical properties of erythrocyte membrane surface[J]. Chin J Pathophysiol, 2015, 31( 9): 1611- 1616. DOI: 10.3969/j.issn.1000-4718.2015.09.014. 聂偲, 佘高明, 李雅兰, 等. 体外循环30 min对红细胞膜的表面结构及力学特性的影响[J]. 中国病理生理杂志, 2015, 31( 9): 1611- 1616. DOI: 10.3969/j.issn.1000-4718.2015.09.014.
[12]	TANG JF, LU AW, ZHU HM, et al. Application of blood cell multi-parameter analysis in the differential diagnosis of large cell anemia disease[J]. Jilin Med J, 2022, 43( 3): 793- 795. DOI: 10.3969/j.issn.1004-0412.2022.03.087. 汤俊峰, 卢爱微, 朱红梅, 等血细胞多参数分析在大细胞性贫血疾病鉴别诊断中的应用[J]. 吉林医学, 2022, 43( 3): 793- 795. DOI: 10.3969/j.issn.1004-0412.2022.03.087.
[13]	KAUSHANSKY K, LICHTMAN MA, PRCHAL JT, et al. Willians Hematology. 9th Edition[M]. New York: McGraw-Hill Education, 2016: 481.
[14]	DENG L, LIU HY. Ultrastructural and morphological changes of red blood cells during extracorporeal circulation[J]. Chin J ECC, 2019, 17( 2): 117- 120. DOI: 10.13498/j.cnki.chin.j.ecc.2019.02.15. 邓丽, 刘宏宇. 体外循环与红细胞损伤[J]. 中国体外循环杂志, 2019, 17( 2): 117- 120. DOI: 10.13498/j.cnki.chin.j.ecc.2019.02.15.
[15]	MURO N, BUJANDA L, SARASQUETA C, et al. Plasma levels of folate and vitamin B(12) in patients with chronic liver disease[J]. Gastroenterol Hepatol, 2010, 33( 4): 280- 287. DOI: 10.1016/j.gastrohep.2009.12.001.
[16]	YANG SS, YE ZL, LIU MY, et al. Associations of different serum folate forms with indices of nonalcoholic fatty liver disease and advanced fibrosis[J]. Obes Res Clin Pract, 2023, 17( 1): 58- 65. DOI: 10.1016/j.orcp.2023.01.004.
[17]	PIANO S, TONON M, VETTORE E, et al. Incidence, predictors and outcomes of acute-on-chronic liver failure in outpatients with cirrhosis[J]. J Hepatol, 2017, 67( 6): 1177- 1184. DOI: 10.1016/j.jhep.2017.07.008.
[18]	VARADARAJAN A, LAL D, KAPIL R, et al. Bone marrow dyspoiesis associated with severe refractory anaemia in liver cirrhosis[J]. Frontline Gastroenterol, 2021, 12( 1): 39- 43. DOI: 10.1136/flgastro-2019-101350.

Relative Articles

[1]	Liver Failure and Artificial Liver Group， Chinese Society of Infectious Diseases， Chinese Medical Association, Severe Liver Disease and Artificial Liver Group， Chinese Society of Hepatology， Chinese Medical Association. Guideline for diagnosis and treatment of liver failure （2024 version）[J]. Journal of Clinical Hepatology, 2024, 40(12): 2371-2387. doi: 10.12449/JCH241206
[2]	Tao HAN, Qian ZHANG. Clinical practice and research advances in artificial liver support therapy[J]. Journal of Clinical Hepatology, 2024, 40(2): 225-228. doi: 10.12449/JCH240201
[3]	Li ZHOU, Yanrong YANG, Yu CHEN. Optimization of non-bioartificial liver technology and research advances in biological artificial liver[J]. Journal of Clinical Hepatology, 2024, 40(2): 239-245. doi: 10.12449/JCH240204
[4]	Shoujuan LI, Li WANG, Ming ZHOU, Bei WU, Lei WANG, Meng DUAN, Hongfan LIAO, Ruiqing HU, Zhaoxia HU, Li ZHU, Juan HU. Efficacy and safety of artificial liver support therapy with a selective plasma separator in low-platelet count patients with acute-on-chronic liver failure[J]. Journal of Clinical Hepatology, 2024, 40(6): 1191-1195. doi: 10.12449/JCH240619
[5]	Jing ZHANG, Xinmin ZHOU. Artificial liver support therapy for patients with pre-liver failure[J]. Journal of Clinical Hepatology, 2024, 40(2): 229-232. doi: 10.12449/JCH240202
[6]	Shuang SUN, Jinquan LIU, Shuai FENG, Shuxian WANG, Xiangmei XU, Deshu DAI, Jianhong WANG, Jinzhen CAI, Chuanshen XU. Successful trans-blood liver transplantation after artificial liver support therapy in a patient with hepatic coma： A case report[J]. Journal of Clinical Hepatology, 2024, 40(4): 791-793. doi: 10.12449/JCH240423
[7]	Yuhang CHEN, Zimeng JIANG, Zhijiao ZHANG, Mengyao ZHENG, Meilian WANG, Hua HUANG, Gongfang ZHAO. The influence of diagnostic criteria of different guidelines on short-term prognosis of artificial liver therapy for acute-on-chronic liver failure[J]. Journal of Clinical Hepatology, 2023, 39(11): 2629-2634. doi: 10.3969/j.issn.1001-5256.2023.11.017
[8]	Tao WANG, Fenghui LI, Jing LIANG. Successful treatment of thyroid storm with liver failure and heart failure using the double plasma molecular absorption system: A case report[J]. Journal of Clinical Hepatology, 2021, 37(5): 1174-1176. doi: 10.3969/j.issn.1001-5256.2021.05.039
[9]	Xiong Zhuang, Liu YangYang, Huo ShaoKai, Gong JiaLian, Jin TianYi, Wang Qiang, Wang HuiLin, Liu TieJun, Leng Yan. Research advances in vitamin K1 in treatment of coagulopathy of liver failure[J]. Journal of Clinical Hepatology, 2019, 35(9): 2099-2103. doi: 10.3969/j.issn.1001-5256.2019.09.048
[10]	Guo XiJu, Guo WeiBo, Zhang JiaChang, Lu YaJing, Yang Yan. Clinical effect of double plasma molecular absorption system in treatment of liver failure due to hyperthyroidism: A case report[J]. Journal of Clinical Hepatology, 2018, 34(7): 1526-1528. doi: 10.3969/j.issn.1001-5256.2018.07.033
[11]	Wang Peng, Zhang ZhiQiao, Lu: GuoTao, Wang GongSui, Chen XiaoQiao, Ming Lang, Zheng Chong, Chen LeWu, Xie QiuLi, He JieXiong, Huang Yong. Clinical value of hemoglobin and its association with hepatocyte steatosis in chronic hepatitis B patients[J]. Journal of Clinical Hepatology, 2017, 33(7): 1274-1279. doi: 10.3969/j.issn.1001-5256.2017.07.014
[12]	Dong DanDan, Yan YouQin. Clinical effect of artificial liver support system on serum hs-CRP level in patients with hepatic failure[J]. Journal of Clinical Hepatology, 2014, 30(10): 1020-1022. doi: 10.3969/j.issn.1001-5256.2014.10.011
[13]	Zhang Lin, Zhao ShouSong. Clinical efficacy of plasma exchange therapy in treatment of liver failure[J]. Journal of Clinical Hepatology, 2014, 30(10): 1015-1019. doi: 10.3969/j.issn.1001-5256.2014.10.010
[14]	Wang GuangYi, Shi XiaoJu, Jiang Chao, Sun XiaoDong, Qiu Wei, Lu: GuoYue. One case of liver transplantation for liver failure due to adult- onset Still's disease[J]. Journal of Clinical Hepatology, 2014, 30(1): 67-68. doi: 10.3969/j.issn.1001-5256.2014.01.018
[15]	Wang Xian, Wang ShaoYang, Huang DeDong, Chen Jian, Chen DeLiang. Analysis of short-term prognostic factors in patients with HBV-related acute-on-chronic liver failure treated with artificial liver support system[J]. Journal of Clinical Hepatology, 2014, 30(4): 367-369. doi: 10.3969/j.issn.1001-5256.2014.04.020
[16]	Zhang AiMin, Xin ShaoJie. Virus infection and liver failure[J]. Journal of Clinical Hepatology, 2012, 28(10): 729-731.
[17]	Zhang WenHua, Jia WenLing, Zhou ZiYing, Tang HaiTao, Wang FengMei. Investigation on the method and safety of the non-heparinized plasma exchange therapy in treating patients with hepatic failure[J]. Journal of Clinical Hepatology, 2012, 28(1): 50-52.
[18]	Zhou XinMin, Dong XuYang. Therapeutic strategies of liver failure for clinical cases[J]. Journal of Clinical Hepatology, 2012, 28(2): 93-98.
[19]	Li ShuangXing, Shi LiJun, Wang XiuJie. Effects of bone marrow mesenchymal stem cells transplantation into rats with acute liver failure[J]. Journal of Clinical Hepatology, 2010, 26(6): 624-626.
[20]	Liang Jing, Kan ZhiChao, Zhang JianDong. The clinical characteristics and treatment of liver failure patients with spontaneous bacterial peritonitis[J]. Journal of Clinical Hepatology, 2010, 26(6): 621-623.

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Figures(3) / Tables(3)

Get Citation

PDF

XML

Article Metrics

Article views (193) PDF downloads(27)

Changes in hemoglobin and related influencing factors in patients with liver failure undergoing artificial liver support therapy

DOI: 10.12449/JCH250116

Abstract

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Changes in hemoglobin and related influencing factors in patients with liver failure undergoing artificial liver support therapy

DOI: 10.12449/JCH250116

Abstract

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content